Category:

Twenty one states have rejected an $18 billion settlement proposal from three major U.S. drug distributors to resolve lawsuits over their alleged role in the opioid crisis, but discussion are still active...More than 2,500 lawsuits have been brought nationwide by states, local and tribal governments over the toll the opioid crisis has taken on their communities...the states objected to a settlement offer sent to the companies’ law firms earlier this week, and were pushing for a larger payment...READ MORE

With federal prosecutors laying waste to Insys' executive team, one big domino was still left to fall: Founder and former CEO John Kapoor, who had a leading role in the drugmaker's opioid kickback scheme. Now, Kapoor will face a stiff prison sentence that sets the bar for executives in the opioid industry...A federal judge in Boston sentenced Kapoor...to five and a half years in prison for his role in a doctor kickback scheme to boost subscriptions of Subsys...READ MORE

The gleaming white booth towered over the medical conference...advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on its walls said...Some conference attendees were stunned when they saw the company logo: Mundipharma, the international affiliate of Purdue Pharma — the maker of the blockbuster opioid, OxyContin, widely blamed for unleashing the American overdose epidemic...Here they were cashing in on a cure...“You’re in the business of selling medicine that causes addiction and overdoses, and now you’re in the business of selling medicine that treats addiction and overdoses?”...“That’s pretty clever, isn’t it?”...“end-to-end provider” — opioids on the front end, and addiction treatment on the back end...READ MORE

When Insys founder John Kapoor was found guilty on federal racketeering charges...it marked the stiffest conviction yet for an opioid executive at the center of the nation's addiction crisis. Now, a federal judge says prosecutors failed to present enough evidence to support some of those claims—likely lowering Kapoor's sentence...Prosecutors failed to present evidence showing...Subsys to be prescribed to patients for nonmedical purposes...The order did not affect the sales fraud charges on which those executives were convicted as part of a long-running scheme to drive up prescriptions of Subsys by underselling the drug's addictive properties and capitalizing on patient titration...READ MORE

The top 1% of opioid prescribers in the U.S. are responsible for 49% of all opioid doses and 27% of all prescriptions, according to a study that suggests efforts to combat overuse of prescription painkillers should concentrate on these heavy prescribers...“We did not know that opioid prescribing was so extraordinarily concentrated in the U.S., well beyond what we see for other medications,”...our study also showed that most U.S. physicians are now prescribing consistent with guidelines (Guidelines from the Centers for Disease Control and Prevention),” Humphreys said by email. “Taken together, these findings suggest that safer prescribing initiatives can be much more focused on the most prolific prescribers.”...READ MORE

The FDA failed to verify whether a program designed to help control the opioid crisis actually worked because of poor oversight, according to a study published...in JAMA Internal Medicine...The findings indicate that the FDA could not determine if the program to train more than 160,000 doctors on cutting back their prescribing of opioids did any good..."What's surprising here is the design of the program was deficient from the start," the study's senior author Caleb Alexander said...READ MORE

Home Depot Inc. executives said the nation’s opioid crisis could be contributing to an unexpected surge in thefts from its stores...The company said organized criminals are stealing millions of dollars’ worth of goods from it and other retailers and storing the merchandise in warehouses. The theft, which retailers call shrink, has gotten so bad that it will narrow Home Depot’s operating profit margins next year, executives said during a meeting with analysts and investors...“This is happening everywhere in retail,” Chief Executive Officer Craig Menear said. “We think this ties to the opioid crisis, but we’re not positive about that.”...READ MORE

Purdue has been identified as "Pharma Co. X," an unnamed opioid maker at the center of a federal kickback probe that netted a $145 million criminal and civil settlement...from Practice Fusion, a subsidiary of Allscripts Healthcare...According to the U.S. Attorney's Office in Vermont, Practice Fusion admitted that it had solicited and received kickbacks from a major opioid company––allegedly Purdue, which shelled out roughly $1 million in payments––in exchange for using its electronic health record software to influence physician prescribing of opioid pain medications..."During the height of the opioid crisis, (Practice Fusion) took a million-dollar kickback to allow an opioid company to inject itself in the sacred doctor-patient relationship so that it could peddle even more of its highly addictive and dangerous opioids,” Christina Nolan, U.S. attorney for the District of Vermont, said in a statement...READ MORE

They were good sons with promising futures who died of drug overdoses less than two months before they were set to graduate from the University of Nevada, Reno...UNR seniors Jordan Watts and Ben Taylor died just 15 days apart in March 2019 from drugs laced with a fatal dose of fentanyl...Their mothers...say their sons were recreational users who bought a couple of pills, unaware they were tainted with the deadly opioid...The dealers pleaded guilty to drug and firearm charges that carry as much as 20 years in prison and fines of $10,000: Alec Donovan...Tyler Winters...Lucas Cueller...at least eight UNR students have died of drug overdoses in Washoe County since 2017...READ MORE

Texas Governor Greg Abbott signed into law HB 2088, which requires that all pharmacists who dispense Schedule II controlled substances provide written notice on the safe disposal of controlled substances unless the dispensing pharmacy is authorized to take back those drugs for disposal, regularly accepts those drugs for safe disposal or provides the patient—at no cost—"chemicals to render the unused drugs unusable" or a mail-in pouch. This law goes into effect on January 1, 2020...DisposeRx, which has a network of more than 2,000 pharmacies in Texas, is working to help pharmacists and pharmacies comply with HB 2088 via safe, at-home disposal packets and patient education...READ MORE